292640-28-9
Chemical Structure
CK2/PIM1-IN-1
- CAS. Nr.: 292640-28-9
- Formula:C15H9NO4S2
- Molecular Weight:331.37
IUPAC Name: (E)-2-(5-((4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid
InChIKey: OTBNRWGTJUMXPA-KPKJPENVSA-N
SMILES: O=C(O)C1=CC=CC=C1C2=CC=C(/C=C(SC(N3)=S)\C3=O)O2
Biological Activity: CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CK2/PIM1-IN-1 | CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords